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Abstract
Motivation: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease caused by aberra-
tions in the genome. While several disease-causing variants have been identified, a major part of
heritability remains unexplained. ALS is believed to have a complex genetic basis where non-
additive combinations of variants constitute disease, which cannot be picked up using the linear
models employed in classical genotype–phenotype association studies. Deep learning on the other
hand is highly promising for identifying such complex relations. We therefore developed a deep-
learning based approach for the classification of ALS patients versus healthy individuals from the
Dutch cohort of the Project MinE dataset. Based on recent insight that regulatory regions harbor
the majority of disease-associated variants, we employ a two-step approach: first promoter regions
that are likely associated to ALS are identified, and second individuals are classified based on their
genotype in the selected genomic regions. Both steps employ a deep convolutional neural net-
work. The network architecture accounts for the structure of genome data by applying convolution
only to parts of the data where this makes sense from a genomics perspective.
Results: Our approach identifies potentially ALS-associated promoter regions, and generally
outperforms other classification methods. Test results support the hypothesis that non-additive
combinations of variants contribute to ALS. Architectures and protocols developed are tailored
toward processing population-scale, whole-genome data. We consider this a relevant first step
toward deep learning assisted genotype–phenotype association in whole genome-sized data.
Availability and implementation: Our code will be available on Github, together with a synthetic
dataset (https://github.com/byin-cwi/ALS-Deeplearning). The data used in this study is available to
bona-fide researchers upon request.
Contact: a.schoenhuth@cwi.nl
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease
affecting the upper and lower motor neurons, resulting in a progressive
loss of muscle strength leading to paralysis and eventually death
(Goldstein and Abrahams, 2013; Phukan et al., 2007). For many
patients ALS is likely caused by genetic aberrations. While a handful of
major genetic risk factors have been identified, no more than 15% of
the heritability has been explained so far (Van Rheenen et al., 2016).
This is because the genetic architecture of ALS has been found to be ra-
ther involved: ALS seems to be evoked through not necessarily additive
combinations of genetic aberrations that individually only have a small
effect and can thus not be detected using the currently available geno-
type–phenotype association approaches (Van Rheenen et al., 2016).
Motivated by these findings, the application of prediction and/or
association schemes that can capture non-additive effects is very
promising. More than that, the evaluation of more complex schemes
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might even be an urgent necessity if one aims at further progress in
predicting ALS, associate it with genetic causes, and, eventually,
also treat it successfully.
In the last 10 years, the identification of genotype–disease rela-
tions has been considerably enhanced by the use of large-scale gen-
ome data. Project MinE is an international initiative to collect
genome data of tens of thousands of ALS patients and healthy con-
trol individuals. Many individuals have been sequenced at consider-
able depth of genome coverage (Project MinE ALS Sequencing
Consortium et al., 2018). The corresponding wealth of data is still
awaiting its full exploration. Clearly, it carries the potential for
pointing out ALS risk factors, guiding further research and drug
development.
Genome-wide association studies (GWAS) are the current state-
of-the-art in analyzing genotype–phenotype data. Statistical tests are
used to determine the level of association between a single genetic
variant and phenotype, and are therefore suitable for uncovering
genotype–phenotype associations that involve single variants or var-
iants interacting with others in additive schemes. GWAS have success-
fully identified disease-associated variants over a wide range of
disorders (Visscher et al., 2017) including ALS (van Es et al., 2009;
Nicolas et al., 2018). However, the approach has been found to be
unable to find the non-additive combinations that are associated with
phenotypes (Wray et al., 2013), which limits its power as genetic var-
iants often constitute phenotype in non-additive combinations. This
could for example be caused by epistasis, where the effect of one vari-
ant on phenotype is dependent on the presence or absence of others
(Frankel and Schork, 1996; Moore, 2003). As above-mentioned, the
genetics underlying ALS have been found to be more involved and are
therefore unlikely to be fully unraveled using basic association
schemes (Van Rheenen et al., 2016). The application of novel data
analysis approaches that account for complex interactions between
genotype input variables and ALS are thus very promising.
Thanks to advances in the recent past, deep neural networks
(DNNs) have turned into powerful classifiers in several application
areas including bioinformatics (Angermueller et al., 2016). They
have been proven to map arbitrarily complex relationships between
multiple input features (in our case genetic variants) and output
labels (here for example binary-valued labels ‘ALS’ or ‘no ALS’). In
addition, DNNs have been pointed out to be particularly big data
compatible (Schmidhuber, 2015). That is, they can handle a consid-
erably larger number of input variables than most other machine
learning methods, a prerequisite for the analysis of genome data.
DNNs therefore hold the clear promise to successfully map complex
genotype–phenotype associations.
DNNs cannot, however, be applied off-the-shelf when mapping
genetic variants to disease (ALS) status; several hurdles need to be
overcome. The first is the size of genome data: the sheer number of in-
put variables (genetic variants, which amount to usually millions)
exceeds the number that these models can deal with easily (a few hun-
dred of thousands). Second, while DNNs can achieve great classifica-
tion accuracy, interpretability is insufficient: it is difficult to
determine why a DNN classified a sample as a case or a control. This
is a major drawback for genotype–phenotype association studies, as
the main goal is to identify (combinations of) variants that associate
with disease rather than obtaining a high classification accuracy.
Third, DNNs have delivered their most striking successes when
applied in image classification tasks. High classification accuracies
were obtained with networks of great depth, employing the hierarch-
ical nature of these images (pixels together form lines, which together
form basic shapes, etcetera). Thereby, the employment of convolu-
tional filters/layers has been crucial in delivering the breakthroughs.
Such filters make use of the position invariance of local structures in
images, a property that does not hold for genome data.
A few studies have considered using deep learning for genotype–
phenotype association studies. Most approaches first reduced the
number of variants included in the model either by selecting variants
that were known to be associated with disease (Hess et al., 2017;
Uppu and Krishna, 2017), or by preselecting those variants that
showed a sufficiently strong correlation with phenotype in a regular
GWAS (Bellot et al., 2018; Monta~nez et al., 2018b). Two studies
combine the latter strategy with the use of autoencoders for further
dimensionality reduction (Fergus et al., 2018; Monta~nez et al.,
2018a). These approaches have the same drawback as a classical
GWAS: already in the preselection step epistasis is overlooked, and
variants that have a small effect on their own will not be included in
further analysis. An alternative approach is proposed by Romero
et al. (2016). The authors limit the computational burden by consid-
ering the transpose of the data matrix, which is similar to consider-
ing features as samples and vice versa, to learn the model
parameters. As the number of genetic features is much larger than
the number of samples in a genotype–phenotype association study,
this leads to a major reduction in the number of trainable parame-
ters and hence strongly reduces the time required for training. Tran
and Blei (2017) define an implicit causal model that aims to identify
relations between variants, and deals with the data dimensionality
by updating the model one variant at the time. In summary, while a
couple of earlier studies have used deep learning to predict pheno-
type from genotype, only two were able to deal with several hun-
dreds of thousands of genetic variants. None have employed the
structure inherent to genome data, and interpretation of the results
has not been addressed in these studies.
This paper presents novel deep neural network architectures and
a protocol by which to predict the occurrence of ALS from individ-
ual genotype data. In summary, we developed a deep learning-based
method that (i) allows for the use of genome-sized data by pre-
selecting parts of the genome that are most relevant for classifica-
tion, (ii) provides insight in which genomic regions are relevant to
classification and (iii) is capable of classifying ALS patients versus
healthy control individuals from genome data. The design of our ap-
proach in general and our network architecture in particular is
driven by the structure of genome data.
We demonstrate in our experiments that by means of our new
architectures, we achieve 77% accuracy in predicting ALS from
genotype data when considering chromosomes 7, 9, 17 and 22. Our
results demonstrate that our ALS-Net clearly outperforms other ma-
chine learning tools and protocols we have been experimenting
with, and drastically outperforms GWAS style prediction technology
based on logistic regression. Our results therefore demonstrate that
prior knowledge on the structure of genome data can aid in the de-
sign of a deep learning-based approach and the neural network
architectures to yield improved accuracy rates in classifying geno-
types with respect to occurrence of ALS. At the same time, we are
aware that here we have only made the first steps toward routine ap-
plication of deep neural networks in classifying genetically involved
diseases from individual genomic profiles. We will point out where
further improvements are conceivable along the way in the follow-
ing, convinced that we are, at the very least, providing a very prom-
ising template for further explorations along this avenue of research.
2 Approach
We propose to make use of prior knowledge to tackle the dimension-
ality issue inherent to working with genome-sized data. The majority
Toward deep learning for GWAS data i539
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of the millions of variants in genome data are irrelevant, as these are
not involved in disease. It has been found in general that most var-
iants that relate to disease phenotypes reside in the DNAse hypersen-
sitive sites (Maurano et al., 2012), that is, in the majority of cases
they occupy the promoter regions preceding genes, where transcrip-
tion is initiated. We therefore focus on the promoter regions.
An interpretable model is able to indicate which genomic regions
were relevant to classification. We therefore developed a two-step ap-
proach to employ neural network architectures for mapping associa-
tions between genotypes and the occurrence of ALS. The first step
consists of individual classifiers for each promoter region, i.e. individu-
als are classified based on their genomic information from a single pro-
moter region only. The classification accuracy obtained with an
individual promoter region is an indication for the region’s predictive
power, and only the eight best performing promoter regions are consid-
ered for further analysis. In the second step the genome information of
the selected promoter regions is combined and an overall classifier is
trained for final classification. This is illustrated in Figure 1, where we
denote the promoter region-specific neural network by Promoter-CNN
(CNN for convolution neural net) and the network that classifies sam-
ples based on a combination of promoter regions by ALS-Net. We de-
velop and validate our approach using GWAS data from the Dutch
cohort of Project MinE, which contains 4511 cases and 7397 controls.
As noted before, the success of DNNs for image classification
heavily relies on the local structures that are present in images.
Genotype data do not convey neighborhood structures that are as
easy to grasp as in images and applying convolution is less straightfor-
ward. Still, genome data does have a neighborhood structure which is
due to two aspects. First, the genome consists of blocks that together
form functional units, such as genes and promoter regions. Second,
genetic variants are passed on from ancestor to offspring in terms of
blocks rather than in isolation. Although in many cases details have
not been fully understood, usually combinations of neighboring var-
iants (haplotype blocks) are responsible for the establishment of phe-
notypes, rather than variants in isolation. This justifies the
application of DNNs that take neighborhood structures into account
(Bellot et al., 2018). Note that the above does not contradict that iso-
lated variants can be indicative of phenotypes: single variants usually
are in linkage disequilibrium with other variants in their block, which
establishes that basic GWAS can nevertheless be successful.
3 Materials and methods
3.1 Project MinE data
We use data collected by Project MinE, a worldwide effort to collect
whole-genome data from both ALS patients and unaffected
individuals for the identification of ALS-causing variants (Project
MinE ALS Sequencing Consortium et al., 2018). The dataset we
used contains solely the Dutch cohort, consisting of 4511 ALS
patients and 7397 healthy individuals including 6127 males and
5781 females.
First SNPs were annotated according to dbSNP137 and mapped
to the hg19 reference genome. Quality control (QC) was first per-
formed per cohort to remove low quality SNPs and individuals using
PLINK 1.9 (Chang et al., 2015; Purcell and Chang, 2015) (–geno
0.1 and –mind 0.1). HapMap3 (Consortium et al., 2010) projected
principal components were calculated and extreme CEU population
outliers were removed (25 standard deviations, SD). Cohorts were
merged into strata based on genotyping platform. Subsequently,
more stringent SNP QC was performed (–maf 0.01, –mind 0.02,
–hwe 1e–5 midp include-nonctrl, –test-mishap excluded P < 1e–8)
followed by more stringent individual QC (–geno 0.02, –het
excluded >0.2, and removed sexcheck failures and missing pheno-
types). We then only kept the autosomal regions. We filtered SNPs
based on differential missingness (–test-missing midp) and excluded
those with a P-value below 1e–4. Finally, we removed duplicated
individuals (PI_HAT > 0.8) and filtered more stringently on popula-
tion outliers (HapMap3: 10SD, 1000 Genomes: 4SD, Stratum itself:
4SD). Strata were then imputed using the HRC reference panel (Das
et al., 2016).
Motivated by the fact that chromosomes 7, 9 and 17 all have
been found to carry elevated amounts of missing heritability (Van
Rheenen et al., 2016), we focus on those chromosomes.
Additionally, we included chromosome 22 that was reported to
have a low level of heritability. The genome data of the four chro-
mosomes contains 823 504 positions of variation.
Note that all chromosomes occur in pairs: one maternal and one
paternal copy. We convert the data, which is in VCF format, to
minor allele frequency data. Hence the data of each individual is a
list of values in {0, 1, 2}, indicating the number of occurrences of the
minor allele at each position on the genome. In some cases informa-
tion for one of the chromosome copies were missing. In such cases,
we assume this to be the frequent allele here. This step can be
improved in future work by eliminating missing values through high
quality imputation.
We focus on the promoter regions. As the position of a promoter
region on the genome is generally not as well defined as the tran-
scription start sites of a gene, and because a deep neural network
requires the data representation for each promoter region to be of
the same size, we used the following approach for determining the
variants that are in the promoter regions. We used the transcription
start sites as reported in the RefSeq database (O’Leary et al., 2015).
The 56 variant positions upstream and the 8 variant positions
Fig. 1. An overview of the workflow. CV, cross validation; acc, accuracy
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downstream of the transcription start site were then included in our
representation of the promoter region. Hence, each promoter region
is represented by a list of 64 values from the set {0, 1, 2}. Note that a
gene can have multiple transcription start sites, and hence multiple
promoter regions.
In summary, the input data to our model for one individual is a
list of vectors in {0, 1, 2}64, where each vector resembles the occur-
rences of the minor allele on the positions in a promoter region.
3.2 Neural network architectures
Promoter-CNN uses two convolution layers followed by two dense
layers. As such (unlike ALS-Net in the following), Promoter-CNN is
not deep, which is justified by the small input. Details of the architec-
ture of Promoter-CNN are presented in Table 1. Batch normalization
is applied after each layer, followed by the softplus activation function.
ALS-Net is a more involved neural network, where the design of
the architecture is based on intuition guided by the structure of gen-
ome data. This will be further explained below. The full network
architecture is shown in Figure 2 with further details in
Supplementary Figure S6 in Section A of the Supplementary
Materials. Note that the network contains several blocks of layers.
These are recurring stackings of convolution and pooling layers, of
which details are provided in Supplementary Figures S7 up to S10 in
Section A of the Supplementary Materials.
The input is formed by concatenating the vectors with genome
information from the individual selected promoter regions to obtain
one vector of length 648 c¼512c, where 64 is the number of
variants in a promoter region, 8 is the number of selected promoter
regions per chromosome and c is the number of chromosomes
included in the analysis. When dealing with all autosomes of a
genome c reaches a maximum of 22, which results in a vector of
length 51222¼11 264. By order of magnitude this scales just
right with the number of training data available (Project MinE: sev-
eral tens of thousand individuals), providing evidence of the poten-
tial to deal with whole genome-sized data.
In the first block of layers each promoter region is considered
separately, that is, the information from different promoter regions
is not yet combined. This allows the model to focus on obtaining a
good representation of the individual promoter regions before com-
bining their information. The first layer of Block 1 is a convolution
layer with stride 64, which ensures that information from separate
promoter regions is not combined, and kernel size 64, which implies
that the information from each promoter region is processed as a
whole (so no convolution within the promoter region). The layer
has 256 output channels, hence 256 functions of the input values of
a single promoter are trained and the information from a promoter
region is now represented by 256 values (see convolution step in
Fig. 3). The second layer is a convolution layer with kernel length 1,
stride 1 and 256 output channels, as proposed by Howard et al.
(2017). This layer takes a linear recombination of the information
from each single promoter region. It does so 256 times with different
weights and biases, once for each output channel. The first two con-
volution layers do not have an activation function. The block is con-
cluded with a batch normalization layer and a rectified linear unit
activation function.
Next, the tensor is reshaped into a 3 dimensional tensor, where
the information of each promoter region is reshaped from a vector
of length 256 to a 16 by 16 matrix (see reshape step in Fig. 3). This
three dimensional tensor can be viewed as an image of 16 by 16 pix-
els with 8c channels, where each channel corresponds to a promoter
region.
In block 2 the promoter regions are combined, hence from this
point onwards the information from the promoter regions is consid-
ered together. The main building blocks of the network are convolu-
tion layers, which allow for learning from large input data without
using an excessive number of trainable parameters. We often employ
three consecutive (separable) convolution layers, which we represent
by block 2 (convolution layers, Supplementary Fig. S8 in the
Supplementary Material) and block 4 (separable convolution layers,
Supplementary Fig. S10 in the Supplementary Material). In block 3
(Supplementary Fig. S9 in the Supplementary Material) convolution
layers are alternated by pooling layers to prevent the model from
overfitting.
Since the underlying classification task requires the model to
identify complex patterns we employ parallel computation blocks
(after block 3) as well as residual connections followed by an ‘add’
operation (inputs to the ‘þ’ operator, dashed arrows in
Table 1. Network architecture of the classifier with input data from
a single promoter region
Layer type Description Output shape
Input (64, 1)
Convolution, BN and Act 1  1 filter, (64, 4)
4 output channels
Convolution, BN and Act 4  4 filter, (61, 32)
32 output channels
Reshape Flatten (1952, 1)
Dense, BN and Act (148, 1)
Dense, BN and Act (16, 1)
Output Softmax (2, 1)
Note: The output shape is given as (width, channels). BN, batch normaliza-
tion; Act, softplus activation.
Fig. 2. An overview of the network, where ‘GAP’ is global average pooling
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Supplementary Fig. S6) to prevent the loss of information in future
layers (He et al., 2016; Szegedy et al., 2015). The model concludes
with two dense layers to combine all information into a single classi-
fication. While dense layers are usually preceded by a flattening of
the output of the previous layer, we make use of a global average
pooling layer instead to allow for a strong dimensionality reduction.
The architecture of ALS-Net is optimized using cross validation,
see the next section for further details.
3.3 Training and testing procedure
The dataset was split into a train-validate set (90% of samples) and
a test set (10% of samples). The train-validate set was used for
model development and selection of the promoter regions, the test
dataset was used only for final testing. To test the model fairly, the
ratio of cases and controls is 1: 1 in the test dataset.
A nine-fold cross validation on the train-validate data was used
to train Promoter-CNN. For each chromosome the eight promoter
regions that achieved the best prediction accuracy averaged over the
nine folds were selected for further analysis. The small network is
trained using stochastic gradient descent on 50 epochs where the
batch size is 64, and with a learning rate of 0.01.
The architecture and other hyperparameters for ALS-Net are
optimized using a nine-fold cross-validation of the train-validate
data. The network architecture was optimized based on the learning
curve and performance measures such as accuracy, precision and re-
call. For examples of the performance of networks that slightly devi-
ate from others as well as a simple multi-layer perceptron, see
Supplementary Table S5 in Section B of the Supplementary
Materials. Additionally we present the performance of a much more
shallow neural network, namely a three-layer MLP, in the last row
of Supplementary Table S5. These results show the necessity of using
a deep network to achieve high recall. Network parameters are opti-
mized using the AdaGrad algorithm (Duchi et al., 2011) with an ini-
tial learning rate of 0.02 and a decay of 2e–4. Optimization was
performed over 300 epochs with a batch size of 32.
The model’s network architecture is optimized based on chromo-
some 7 only, and used for all four chromosomes individually as well
as for the combination of the four chromosomes. Parameters are
optimized separately for each chromosome as well as for the com-
bined model.
The performance of our approach was tested by applying ALS-
Net to the test data. Hence for these samples we only use the
selected promoter regions.
3.4 Comparison with other machine learning
approaches
The performance of ALS-Net is assessed using the test data, and is
compared with the performance of logistic regression—this corre-
sponds with the approach for calculating a basic polygenic risk score
(PRS) (Dudbridge, 2013), support vector machine [SVM (Joachims,
1998; Vapnik, 1998)], random forest (Breiman, 2001) and
AdaBoost (Freund et al., 1999; Friedman et al., 2000). For each of
these we used the same promoter regions as for the large neural net-
work. Hyperparameters were optimized using a cross validation ap-
proach, and performance on the test dataset is reported.
In logistic regression a linear function is used to estimate the dis-
ease risk score from genotype, followed by a classification where
samples with a predicted risk score above a predetermined threshold
are considered as positives (in our case ‘ALS’) and the others as neg-
atives (in our case ‘no ALS’). While GWAS uses a single genetic vari-
ant as explanatory variable, we base our prediction of disease status
on multiple variants, as is common for the calculation of the PRS.
We apply logistic regression to the full set of promoter regions as
well as to the variants that reside in the promoter regions selected by
Promoter-CNN. Note that the choice of threshold determines the
balance between precision and recall. In order to allow for compari-
son with the other methods, we chose the threshold such that accur-
acy on the training set is maximized.
SVM is a popular binary classification method designed to find a
non-linear boundary (determined by the kernel function) to maxi-
mize the margin between two clusters. Here we used a radial basis
function SVM with kernel coefficient 0.001.
Random forest is a widely used machine learning algorithm that
creates multiple decision trees and combines their individual classifi-
cations to abstract a final classification. Using a large number of de-
cision trees is required for higher accuracy, but also results in slow
training. We implement a random forest consisting of 100 trees with
maximum depth 5, and at most 100 features will be considered
when looking for the best split.
The core idea of AdaBoost is to train several decision trees, as-
sign weights to samples and classifiers to force the algorithm to
focus on hard-to-classify samples, and combine the weighted classi-
fications to form a stronger final classifier. While the model is
powerful and yields explainable results, it is sensitive to outliers. We
used AdaBoost with 1000 decision trees of depth 3.
4 Results
4.1 Single promoter classifiers select known
ALS-associated genes as well as potential
novel risk factors
Figure 4 shows histograms of the classification accuracy for the sin-
gle promoter classifiers, organized per chromosome. While most
promoter regions lead to an accuracy around 0.5—the same as ran-
dom—the distribution has a tail on the right with a few promoter
regions achieving higher accuracy. Hence only a few promoter
regions have the potential to aid in classification of cases versus
controls.
The genes that the selected promoter regions correspond to are
listed in Table 2 together with the accuracy, precision and recall
obtained with Promoter-CNN. Some of these genes have been asso-
ciated with ALS or other neurological disorders before, while others
can be viewed as potential novel ALS-associated genes. The accura-
cies for these promoter regions obtained by running a logistic regres-
sion are presented as well (Acc LR). The results show that using
logistic regression would have resulted in a partially different
Fig. 3. Change of tensor shape throughout Block 1 and Reshape
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selection of promoter regions. Recall that multiple promoter regions
can correspond to a single gene, as a gene can have multiple tran-
scription start sites. See also Supplementary Table S7, Section D in
the Supplementary Materials for some annotations (known gene
ontology classes) for genes selected in chromosome 7. While the
polymorphic loci in the selected promoters are important as input
for successful deep learning based classification, we do not yet pro-
vide clear evidence whether, and if so how, the selected genes are
associated with ALS, which is important to keep in mind. Please
also see (Biedrzycki et al., 2019) for a (warning) discussion.
Several genes that were associated with ALS by earlier studies
are not among the top eight performing promoter regions from
Promoter-CNN. The classification accuracies from Promoter-CNN
for the ALS-associated genes reported by Abel et al. (2013) are listed
in Supplementary Table S6 in Section C of the Supplementary
Materials.
4.2 ALS-Net outperforms other classifiers in terms of ac-
curacy and recall
The selected promoter regions were included in a final overall classi-
fier. We compared the performance of ALS-Net with logistic regres-
sion, SVM, random forest and AdaBoost (indicated by Promoter-
CNN þ classifier, Table 3). Additionally, we compare the results of
Promoter-CNN with the five classifiers to logistic regression on allFig. 4. Histograms of per-promoter region test accuracies for each chromosome
Table 2. Promoter regions selected by the deep neural network for individual promoters
Positions (range) Gene Acc Prec Recall Acc LR
Chr 7 108000837–108023643 LAMB4 0.582 0.679 0.313 0.548
60061–93116 LOC105375113 0.579 0.728 0.252 0.544
108001655–108023688 LAMB4 0.576 0.668 0.304 0.548
157112225–157119549 LOC105375607 0.576 0.745 0.230 0.506
142254448–142274025 TRY2P 0.567 0.717 0.222 0.545
72317552–72663411 TYW1B 0.566 0.672 0.259 0.507
68920–94119 LOC101929756 0.566 0.672 0.259 0.538
76486174–76514143 DTX2 0.562 0.719 0.210 0.522
Chr 9 136334910–136355183 GPSM1 0.615 0.694 0.412 0.577
136336933–136357677 GPSM1 0.611 0.693 0.398 0.571
136361582–136378662 SNAPC4 0.609 0.635 0.514 0.578
136370707–136389390 SNAPC4 0.603 0.677 0.395 0.565
134626387–134643306 COL5A1 0.600 0.710 0.338 0.5621
98535635–98557461 LOC105375972 0.595 0.753 0.282 0.561
136324634–136347520 GPSM1 0.581 0.653 0.345 0.540
136382485–136403936 SDCCAG3 0.581 0.673 0.314 0.537
Chr 17 67877749–67891928 BPTFb 0.592 0.793 0.250 0.555
15614822–15661462 TRIM16 0.591 0.793 0.250 0.561
138726–158754 DOC2Ba 0.582 0.603 0.477 0.512
139747–159851 DOC2Ba 0.579 0.593 0.506 0.510
141150–160523 DOC2Ba 0.577 0.599 0.464 0.0.51
55245746–55267188 HLF 0.577 0.747 0.234 0.578
55247456–55268383 HLF 0.577 0.745 0.230 0.564
139853–160092 DOC2Ba 0.573 0.601 0.434 0.505
Chr 22 19403582–19439165 HIRA 0.575 0.694 0.267 0.560
19404552–19439540 HIRA 0.567 0.694 0.267 0.558
17230116–17293295 CECR1 0.529 0.627 0.141 0.508
19685895–19718733 LINC00895 0.520 0.554 0.207 0.500
17747340–17783351 BID 0.518 0.598 0.113 0.511
17760620–17788896 MIR3198-1 0.517 0.589 0.111 0.500
19149580–19162696 GSC2 0.517 0.647 0.074 0.500
17541582–17566229 CECR2 0.515 0.725 0.049 0.502
Note: Accuracy (Acc), precision (Prec) and recall obtained with Promoter-CNN are reported. Additionally, the accuracy for this promoter region obtained
with logistic regression is reported (Acc LR).
aReported as ALS associated gene (http://alsod.iop.kcl.ac.uk/) (Abel et al., 2013).
bReported to be associated with ALS and other neurodegenerative disorders (https://www.wikigenes.org/e/gene/e/2186.html).
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promoter regions, so without the help of Promoter-CNN. This was
only possible for the individual chromosomes, as a logistic regres-
sion on all promoter regions from the four chromosomes combined
required too much RAM. SVM, random forest and AdaBoost could
not deal with the full chromosome data of even a single chromo-
some. The methods are compared based on classification accuracy,
precision, recall and the F1 statistic for each chromosome separately
as well as for their combination, and results are presented in
Table 3.
First note that the classification accuracy of logistic regression is
improved by Promoter-CNN. Second, Promoter-CNN þ ALS-Net
outperforms all other methods in terms of accuracy, closely followed
by Promoter-CNN þ logistic regression. Both methods largely out-
perform SVM, random forest and AdaBoost. Third, Promoter-CNN
þ ALS-Net almost always yields the highest recall, but is almost al-
ways outperformed by logistic regression, SVM and random forest
in terms of precision—i.e. ALS-Net is better at identifying ALS
patients (lower number of false negatives) but classifies healthy con-
trols more often as patients than the other methods (higher number
of false positives). Thus, each of the methods provides a different
trade-off of precision versus recall. We therefore also consider the
F1-statistic, a combined measure of precision and recall. Our deep
neural network outperforms the other methods in terms of the F1
statistic for three out of the four individual chromosomes as well as
the combination of chromosomes.
4.3 Including more genomic information improves
classification
For most models the highest accuracy is obtained when the four
chromosomes are combined rather than considering each chromo-
some individually. This does not hold for Promoter-CNN þ
Random Forest, which is likely due to the fact that a larger forest
would be required to be able to deal with the larger dataset that is
obtained when combining the four chromosomes. Since this slows
down training times considerably, the applicability of random for-
ests on genome-sized data remains (more than) questionable.
4.4 Potential identification of disease-associated var-
iants with ALS-Net
In order to identify which input features (in our case, genetic var-
iants) were relevant for a neural network’s classification of a single
sample one can make use of saliency maps. These are heatmaps that
show the gradient of the objective function with respect to each in-
put feature. A large absolute value indicates a strong influence of
this feature on the final classification. We have constructed saliency
maps for 100 randomly sampled ALS patients and 100 randomly
sampled healthy controls. The average saliency maps for cases and
controls are shown in Figure 5. As can be seen from these figures,
the most important features tend to be upstream of the genes, and
are likely to show early (in 50–30 order) in the promoter regions
(dark blue parts).
4.5 ALS-Net is less sensitive to batch induced confound-
ing effects
Genome sequences were obtained in 4 batches (C1, C3, C5, C44).
Disease status is highly confounded with the batch an individual
belongs to: the number of cases/controls was 226/380 for batch C1,
131/49 for batch C3, 0/5156 for batch C5 and 4154/1812 for batch
C44. Together C44 and C5, two highly unbalanced batches, cover
approximately 93% of the individuals. A classifier may thus achieve
good accuracy on predicting disease status by picking up batch-
related data structures rather than disease-associated genetic
characteristics. If a classifier picks up differences between C5 and
C44, instead of between case (ALS) and control (no ALS), the classi-
fier will fail to make reasonable predictions in C1 and C3, which
still cover 786 individuals. Since both C1 and C3 are fairly balanced
in terms of case-control labels, batch labels cannot be confounded
with true case/control labels as easily as in C5 and C44. To check
whether Promoter-CNN þ ALS-Net (our approach) and Promoter-
CNN þ Logistic Regression (as the second best classifier evaluated)
pick up on disease status rather than batch effects during training
we evaluated the performance of these two within the individual
Table 3. Classification results obtained with four classification
methods applied to chromosomes 7, 9, 17 and 22 independently
and combined
Classifier Chr Accuracy Precision Recall F1-Score
Logistic Regression 7 0.625 0.642 0.566 0.602
9 0.546 0.575 0.355 0.439
17 0.637 0.670 0.539 0.598
22 0.590 0.619 0.467 0.533
Promoter-CNN
þ ALS-Net
7 0.675 0.667 0.695 0.681
9 0.729 0.698 0.808 0.749
17 0.688 0.725 0.606 0.661
22 0.617 0.601 0.410 0.517
All 0.769 0.711 0.908 0.797
Promoter-CNN þ
Logistic Regression
7 0.635 0.728 0.445 0.553
9 0.683 0.743 0.560 0.685
17 0.642 0.734 0.445 0.554
22 0.580 0.714 0.299 0.422
All 0.739 0.759 0.699 0.728
Promoter-CNN þ SVM 7 0.550 0.750 0.151 0.252
9 0.598 0.790 0.266 0.397
17 0.577 0.788 0.212 0.334
22 0.521 0.743 0.267 0.393
All 0.725 0.783 0.624 0.694
Promoter-CNN þ
Random Forest
7 0.562 0.776 0.175 0.285
9 0.579 0.759 0.229 0.351
17 0.645 0.762 0.420 0.542
22 0.587 0.745 0.265 0.391
All 0.596 0.813 0.249 0.381
Promoter-CNN þ
AdaBoost
7 0.604 0.642 0.467 0.541
9 0.621 0.668 0.481 0.559
17 0.599 0.633 0.472 0.401
22 0.561 0.591 0.398 0.475
Al 0.661 0.700 0.565 0.625
Note: The result of best performing model for the given (set of) chromo-
some(s) is denoted in italic, while the overall best score is indicated in bold.
Chr, chromosome.
Fig. 5. Saliency maps averaged over (a) 100 randomly selected ALS patients
and (b) 100 randomly selected healthy controls
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batches on the training data. As can be seen in Table 4 both classi-
fiers achieve good accuracy within batches C5 and C44, for which it
remains unclear whether the classifiers predict batch labels rather
than true labels. On C1 and C3 Promoter-CNN þ Logistic
Regression fails to bring up competitive performance rates (in par-
ticular: precision/recall logistic regression: 0.48/0.37 on C1 and
0.77/0.31 on C3), while Promoter-CNN þ ALS-Net keeps signifi-
cantly better performance rates (precision/recall: 0.51/0.79 on C1,
0.83/0.76 on C3), a clear indication that ALS-Net picks up truly
ALS related effects to a substantial amount. For logistic regression
however, it is likely that batch effects have been picked up, which
lead to random classification in batches C1 and C3.
While ALS-Net comes with the clear promise to be (consider-
ably) less prone to picking up batch effects, we conclude to say that
correcting for confounding effects for CNN based methods still
requires (most interesting!) further research.
4.6 Runtimes of ALS-Net are acceptable
Promoter-CNN was run on a CPU cluster. The training process for
a single promoter region takes around 200 s. Note that training of
the promoter regions can be done in parallel on a multi-processor
system. ALS-Net was trained on a GPU (Nvidia TitanX). For the
largest model, which classified individuals based on information
from the four chromosomes combined, the model needed 500 s and
10GB of RAM for training.
5 Discussion
In this work we presented a novel deep learning-based approach for
genotype–phenotype association studies on genome-sized data that
has the potential to identify phenotype-associated genomic regions.
By making use of earlier evidence that regulatory elements harbor
the majority of disease-associated variants we developed a two-step
approach, and designed a neural network where we made use of the
structure of genome data by first considering each promoter region
separately, and then combining their information in later layers. The
combination of Promoter-CNN with ALS-Net has several advan-
tages: it (i) can easily be extended to handle genome-sized data, (ii)
identifies regions of the genome that are relevant to classification of
ALS patients versus healthy controls and (iii) yields good classifica-
tion results.
ALS-Net generally outperforms other methods in terms of classi-
fication accuracy, followed by Promoter-CNN aided logistic regres-
sion. As for prior related work, note that Bellot et al. (2018)
observed small improvements of CNN based methods over logistic
regression in several, but not all cases. Here we observe some
marked improvements of Promoter-CNN þ ALS-Net over logistic
regression. An explanation might be that Bellot et al. (2018) use a
(substantially) simpler (less deep) network architecture and make a
pre-selection of genetic features based on linear models, and hence
overlook non-additive interactions already in the pre-selection step.
ALS-Net outperforms all other methods in terms of recall, also
called power. This indicates that our approach might point out ways
to overcome the (notoriously complained) lack of power that arises
from the use of linear models when associating genotypes with pheno-
types that underlie more involved genetic architectures. Additionally
further examination of what caused the increase in true case predic-
tions might yield novel insight in the genomic mechanisms underlying
ALS. Overall, ALS-Net provides a better trade-off between precision
and recall as measured by the F1 statistic, which finally documents its
value as a predictor in general.
Note that all methods have been helped by our two-step ap-
proach: the classification performance of logistic regression goes up
when combined with Promoter-CNN, while none of the other meth-
ods evaluated were able to process chromosome-sized genotype data
without pre-selecting features.
Our results support the belief that ALS is caused by non-linear
combinations of variants, which was hypothesized before by Van
Rheenen et al. (2016). Table 3 shows a low recall for each of the in-
dividual promoter regions. Combining these into a single classifier
improves recall for PromoterCNN þ ALS-Net up to a level that far
exceeds the recall obtained by PromoterCNN þ logistic regression.
This implies that the promoter regions on the different chromo-
somes interact in a non-additive way.
The two-step approach allows for the identification of potential
ALS-associated genomic regions: Promoter-CNN selects promoter
regions that are potentially associated with ALS. This information is
then used by ALS-Net for classification. Our analysis has identified
several promoter regions that potentially contribute to ALS preva-
lence, some of which are known to be associated with ALS. On the
other hand, several ALS-associated genes (Abel et al., 2013) were
not selected by Promoter-CNN. This does not necessarily imply that
Promoter-CNN gave low prediction accuracies for these promoter
regions: they simply were not among the eight most predictive pro-
moter regions. Four out of the nine ALS-associated promoter regions
that were not selected by Promoter-CNN were among the 5% best
performing promoter regions (for these promoter regions, Promoter-
CNN achieved an accuracy above 0.518, 0.513 and 0.520 for chro-
mosomes 7, 9 and 17 respectively, see Fig. 4). Despite missing some
of the known ALS-associated genes, our final classification, which
did not use any information from these genes, was able to classify at
high accuracy. Further research is required to understand this.
The architecture of ALS-Net was optimized for chromosome 7.
When applying this architecture to classify samples from the test set
based on genotype data from chromosomes 9, 17 and 22 as well as
their combination, the model performed very well and there was no
need for further adjustment of the network architecture. These
results show that our network architecture generalizes well to un-
seen data, even to data from a different chromosome or set of chro-
mosomes. Since beyond generally applicable genetics principles we
have not made use of particular ALS related knowledge, we believe
that our architectures hold the potential to be applicable more uni-
versally. Further such experiments, however, predominantly depend
on the availability of cohorts of sizes equal to the rather large
cohorts we have been investigating here—which will be possible for
ever more diseases in the mid-term future.
Table 4. Training accuracy, precision and recall for each cohort,
obtained with Promoter-CNN þ Logistic regression and Promoter-
CNN þ ALS-Net
Classifier Batch Accuracy Precision Recall
Promoter-CNN þ ALS-Net C1 0.648 0.510 0.793
C3 0.711 0.829 0.757
C5 0.934 0.000 N/A
C44 0.760 0.753 0.967
Promoter-CNN þ Logistic
Regression
C1 0.626 0.480 0.373
C3 0.434 0.766 0.313
C5 0.990 0.000 N/A
C44 0.657 0.740 0.768
Note: In C5 there are no cases, implying that TP and FN counts are zero,
which renders precision (¼0) and recall (¼undefined) statistics meaningless in
the frame of a comparison.
Toward deep learning for GWAS data i545
D
ow
nloaded from
 https://academ
ic.oup.com
/bioinform
atics/article-abstract/35/14/i538/5529261 by C
W
I-C
entrum
 v W
iskunde en Inform
 user on 25 July 2019
A major issue for genotype–phenotype association studies has
been the large number of input variables, which causes issues for
most machine learning approaches. To the best of our knowledge,
there has so far been no method that can deal with more than half a
million of genetic variants other than GWAS (where one tests for
the association of a single variant with genotype) or approaches
where GWAS or prior knowledge was used for pre-selecting relevant
variants. This makes our approach the first that accounts for non-
additive interactions between genomic features right from the start.
We view our work as a first step toward biology-informed deep
learning for association studies. We would like to emphasize that the
current work is not a ready-to-use method that identifies relations be-
tween SNPs and phenotype, as one does in a GWAS. In fact, we do
not envision that deep learning will lead to the identification of asso-
ciations between individual SNPs and phenotype: instead, we expect
that deep neural networks in the future will be able to identify combi-
nations of genetic characteristics that are associated with disease. For
example, this manuscript shows how deep learning can be used to se-
lect potentially relevant promoter regions. The purpose of the current
work is to show the potential of deep learning when it comes to classi-
fication and present an approach that tackles some of the main issues
when applying deep neural networks to genotype data.
While our results are promising, several improvements can still
be made. By analyzing promoter regions individually with
Promoter-CNN the approach is capable of detecting non-linear
interactions within a promoter region. While non-linear interactions
across promoter regions cannot be detected at this point, ALS-Net
will pick up interactions across the Promoter-CNN selected pro-
moters. Note that ALS-Net cannot take all promoters as input, be-
cause the input would be too large. One can thus consider
Promoter-CNN as CNN based feature selection. Interesting future
work therefore is to increase the number of promoters that ALS-Net
can cover. Also the number of included promoter regions may be
chosen to be dependent on the length or the expected contribution
to heritability of the chromosome under consideration.
Additionally, an even deeper model may improve performance as
well. We plan to further develop these methods in the future.
While this work presents a methodology for the analysis of geno-
type–phenotype data, refinements are required before practical im-
plementation. For example, in our analysis we did not account for
population stratification. As we first focus on the development of
the neural network-based approach, we leave such improvements
for future research.
The framework of our approach allows for analyzing full gen-
ome data. The pre-selection step of promoter regions is very fast and
highly parallelizable, as Promoter-CNN is run on the promoter
regions separately. Only the selected promoter regions are used as
an input to ALS-Net. This input contains 22*64*k¼1408k varia-
bles (where 22 reflects the number of all autosomes, and k is the
number of promoter regions selected per chromosome). This means
11 264 variables when k¼8, an input size that is well manageable
for a deep neural network. We may need to re-optimize the network
architecture to achieve an optimal level of accuracy.
Even though our analysis was limited to the genomic informa-
tion of only four chromosomes, we obtained a high level of classifi-
cation accuracy. We plan to extend our work by including all
chromosomes, which we expect to result in a strong increase in clas-
sification accuracy, as well as the identification of more potential
ALS-associated promoter regions. Additionally, Project MinE is a
worldwide ongoing effort, and we plan to apply our methods to the
full dataset to strengthen our results once this data becomes fully
available.
6 Conclusion
In this paper we presented ALS-Net, a convolutional neural network
approach to predict ALS prevalence from genotype data. In order to
employ the strengths of convolution we have developed a two-level
approach where we focus on promoter regions, which are known
sensitive sites for disease-causing variants. The architecture of the
final classification network employs the strength of convolution and
the structure of genome data by applying convolution filters to indi-
vidual promoter regions. The results of our tests are promising, and
are expected to generalize to genome regions that were unexplored
in this work. Additionally, this work shows that deep learning is a
highly promising approach for the identification of complex geno-
type–disease relations. We view our approach as a first step toward
deep learning for genotype–phenotype association analysis guided
by regulatory principles.
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